Home Just In Cigniti Technologies supports Belagavi Institute of Medical Sciences with medical equipment

Cigniti Technologies supports Belagavi Institute of Medical Sciences with medical equipment


The ICU unit at Belagavi Institute of Medical Sciences has been renovated by bringing in new medical equipment with the support of Cigniti Technologies. Inauguration of the ICU happened in the virtual presence of Paul Trotter, Dy. CTO at Atom, Srikanth Chakkilam, CEO at Cigniti Technologies and Krishnan Venkatachary, CFO at Cigniti. Dr. Viveki, Director, BIMS, and Mayur Patnala, Founder and CEO, Nirmaan Organization have graced the occasion at the Hospital.

Cigniti Technologies, the world’s leading independent Quality Engineering and Software Testing services company, partnered with the Nirmaan Organization to provide medical equipment to the ICU ward of Belagavi Institute of Medical Sciences (BIMS) in the Belagavi district of Karnataka. Cigniti donated ECG machines, oxygen cylinders, X-ray machines, air conditioners for the ICU ward, computers for the hospital staff, crash carts, ICU medical trolleys, surgical trolleys, suction apparatus, NIV masks, and other medical equipment to the hospital to support India’s fight against COVID-19.

“As a socially responsible organization, we’re committed to supporting India’s recovery from the COVID-19 second wave. We are happy to be a part of this project to improve Karnataka’s medical infrastructure, which will help rural residents get better healthcare during and after the pandemic,” said Srikanth Chakkilam, Chief Executive Officer of Cigniti Technologies on the occasion.

“We thank Cigniti and Nirmaan for supporting BIMS Belagavi with crucial ICU medical equipment. The much-needed oxygen cylinders and NIV masks will help the hospital supplement their oxygen supplies and prepare for future emergencies.” Dr. Viveki, Director, BIMS.

Recommended for You

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Close Read More

See Ads